安全性による妊娠中絶の世界的,地域的,次地域的分類,2010年−14年:ベイジアン階層モデルによる推定
Bela Ganatra1, Caitlin Gerdts2, Clémentine Rossier3
1UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland.
Lancet (London, England)
|October 2, 2017
まとめ
世界的に見ると,2010年から14年の間における中絶の45%は安全ではなく,発展途上国や規制の厳しい法律によってその割合は高くなっています. 世界中で安全な中絶サービスへのアクセスを確保するために,努力を増やすことが不可欠です.
科学分野:
- 生殖 健康
- 世界保健
- 医療 統計
背景:
- 過去の世界的な不安全な中絶の推定値は1995年,2003年,2008年でした.
- 医療中絶やミソプロストールの使用が公式のシステム以外で増加しているため,推定方法の再概念化が必要である.
- 妊娠中絶の安全性に影響を与える要因は,更新された会計が必要です.
研究 の 目的:
- 妊娠中絶のグローバル,地域,および亜地域分布を安全性カテゴリーで推定する.
- 安全な中絶と不安全な中絶に関する最新のデータを提供するためです.
主な方法:
- 妊娠中絶の方法,提供者,設定,安全性の要因に関する経験的データを活用した.
- ベイジアン階層モデルを用いて推定した.
- WHOの定義とガイドラインに基づいて,安全で,安全でないと,最も安全でないと分別しました.
主要な成果:
- 2010 年 から 2014 年 まで の 間,全世界 で 毎年 推定 5570 万 件 の 中絶 が 行なわ れ まし た.
- これらの中絶の54.9%は安全で,45.1%は危険でした.
- 開発途上国 (49.5%) と先進国 (12.5%) と非常に制限的な法律を持つ国では不安全な中絶が不釣り合いに高かった.
結論:
- 安全な中絶へのアクセスを改善するために,特に発展途上国では,大きな努力が必要である.
- 経験的なデータの不足は重要な制限であり,国内保健サービスのデータを改善する必要がある.
- データのギャップを埋め,将来の見積もりを洗練するには,革新的な研究が必要です.
関連する概念動画
Statistical Methods for Analyzing Epidemiological Data
1.0K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.0K
Comparing the Survival Analysis of Two or More Groups
637
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
637
Relative Risk
2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
491
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
491
Hazard Ratio
644
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
644
Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K


